文献速递免疫规划传染病防控与疫情报告

季节性四价流感疫苗与COVID-19疫苗联合接种可增强未免疫小鼠对流感病毒的免疫应答并降低对SARS-CoV-2的免疫应答

Co-administration of seasonal quadrivalent influenza and COVID-19 vaccines leads to enhanced immune responses to influenza virus and reduced immune responses to SARS-CoV-2 in naive mice.
PubMed 文献 · Vaccine · 2025-02-07

本研究在未免疫BALB/c小鼠中评估四价流感疫苗(QIV)与辉瑞-BioNTech mRNA COVID-19疫苗(BNT162b2)联合接种的保护效力与体液免疫应答,采用对侧肢体、同侧肢体及两疫苗混合三种方式。结果显示联合接种组血凝抑制(HAI)和结合抗体滴度显著高于仅接种QIV组,尤以同侧和混合组明显;但同侧接种和混合接种对SARS-CoV-2结合与中和滴度有轻微负面影响。

要点

  • QIV与BNT162b2联合接种组HAI和结合抗体滴度显著高于仅接种QIV组。
  • 同侧接种和混合接种对SARS-CoV-2结合与中和滴度有轻微负面影响。
  • 结果支持联合接种可诱导针对两种病原体的强抗体应答的假设。

核心结论

  • QIV与COVID-19 mRNA疫苗联合接种可诱导针对两种病原体的强抗体应答,但同侧接种和混合接种对SARS-CoV-2结合与中和滴度有轻微负面影响。

研究设计与样本

  • 在未免疫BALB/c小鼠中评估QIV与BNT162b2联合接种的保护效力和体液免疫应答,设对侧肢体、同侧肢体及两疫苗混合三种联合接种方式。

主要发现

  • 联合接种QIV与COVID-19 mRNA疫苗组HAI和结合抗体滴度显著高于仅接种QIV组,尤以同侧和混合组明显。
  • 同侧接种和混合接种对SARS-CoV-2结合与中和滴度有轻微负面影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The ongoing co-circulation of influenza viruses and severe acute respiratory disease coronavirus 2 (SARS-CoV-2) presents significant public health challenges. Vaccination is a pivotal tool to tackle infections and severe disease. Administering both the influenza and coronavirus disease 2019 (COVID-19) vaccines simultaneously could simplify vaccine delivery and is already practice in several countries. In this study, we assessed the protective efficacy and humoral immune responses elicited by concomitant administration of a quadrivalent influenza vaccine (QIV) and the Pfizer-BioNTech mRNA COVID-19 vaccine (BNT162b2) in naïve BALB/c mice. We included three ways of co-administration: a) both vaccines at contralateral limbs, b) both vaccines at ipsilateral limbs and c) admixture of the two vaccines before administration. The last regimen was included since it has been shown that the lipid nanoparticles used for mRNA vaccines can also have an adjuvant effect on protein-based antigens. Notably, co-administration of QIV and COVID-19 mRNA vaccine led to significantly higher hemagglutinin inhibiting (HAI) and binding antibody titers compared to QIV only vaccination, especially in the ipsilateral and admixed groups. Conversely, ipsilateral administration and administration of an admixed vaccine had a slightly negative impact on SARS-CoV-2 binding and neutralization titers. These findings support the hypothesis that the co-administration of QIV and COVID-19 mRNA vaccines can induce robust antibody responses, which are indicative of protective immune responses against both infectious agents.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Abbad A, Yueh J, Yellin T, et al. Co-administration of seasonal quadrivalent influenza and COVID-19 vaccines leads to enhanced immune responses to influenza virus and reduced immune responses to SARS-CoV-2 in naive mice. Vaccine. 2025. PMID: 39921982. doi:10.1016/j.vaccine.2025.126825

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。